Abstract:Significance The combination of chemotherapy and photodynamic therapy opens up a promising way of overcoming drug resistance, incorporating different mechanisms of actions to achieve synergistic efficacy. However, the antitumor outcome of photodynamic therapy is greatly limited due to the unsatisfactory singlet oxygen generation caused by severe aggregation of the photosensitizer. To this end, we utilize a discrete metallacage containing therapeutic organoplatinum(II) to encapsulate a photosensitizer by forming an inclusion host–guest complex, facilitating the codelivery of chemotherapeutic agent and photosensitizer through nanoformulation. Benefiting from the enhanced permeability and retention effect and active targeting, the nanomedicine exhibits satisfactory antitumor performance against drug-resistant tumor. This pioneering work provides a distinct supramolecular methodology to prepare theranostic systems for multimodality imaging and therapy. Although platinum-based anticancer drugs prevail in cancer treatment, their clinical applications are limited by the severe side effects as well as their ineffectiveness against drug resistant cancers. A precise combination of photodynamic therapy (PDT) and chemotherapy can synergistically improve the therapeutic outcome and thereby may overcome drug resistance through a multipronged assault. Herein, we employ the well-defined cavity of a discrete organoplatinum(II) metallacage (M) to encapsulate octaethylporphine (OEP), a photosensitizer, forming a dual-functionalized system M⊃OEP that is wrapped into the hydrophobic core of the nanoparticles (MNPs) self-assembled from an amphiphilic diblock copolymer. Using a copper-free click reaction, a targeting ligand is conjugated on the surface of the MNPs, aiming to specifically deliver a chemotherapeutic drug and a photosensitizer to cancer cells. Benefiting from the enhanced permeability and retention effect and active targeting capability, high tumor accumulation of MNPs is achieved, leading to an improved therapeutic outcome and reduced side effects. In vivo studies demonstrate that the combination of chemotherapy and PDT exhibits a superior antitumor performance against a drug-resistant tumor model attributed to their synergistic anticancer efficacy.

Host-guest Binding of Tetracationic Cyclophanes to Photodynamic Agents Inhibits Posttreatment Phototoxicity and Maintains Antitumour Efficacy.

Supramolecular photosensitizers using extended macrocyclic hosts for photodynamic therapy with distinct cellular delivery

Giant Macrocycle Overcomes the Post-Treatment Phototoxicity of Photofrin through Host-Guest Complexation

Photodynamic Therapy: when Van Der Waals Heterojunction Meets Tumor

Host−guest Complexation-Mediated Codelivery of Anticancer Drug and Photosensitizer for Cancer Photochemotherapy

Porphyrin-Camptothecin (CPT) Grafted Polyoxazoline Amphiphiles for Tumor Photodynamic-Chemotherapy Combination Treatment

Substitution Activated Precise Phototheranostics through Supramolecular Assembly of AIEgen and Calixarene

Polymorphic Supramolecular Therapeutic Platforms with Precise Dye/Drug Ratio to Perform Synergistic Chemo‐Photo Anti‐Tumor Therapy and Long‐Term Immune Protection

Antitumor Therapy through Photothermal Performance Synergized with Catalytic Activity Based on the Boron Cluster Supramolecular Frameworks

Multifunctional Tetracene/Pentacene Host/Guest Nanorods for Enhanced Upconversion Photodynamic Tumor Therapy

Stimuli-responsive Supramolecular Amphiphilies Constructed Via Host–guest Interaction for Photodynamic Therapy

Compact Molecular Conformation of Prodrugs Enhances Photocleaving Performance for Tumor Vascular Growth Inhibition

A Dynamic Tetracationic Macrocycle Exhibiting Photoswitchable Molecular Encapsulation

Enhancing the Photosensitivity of Hypocrellin A by Perylene Diimide Metallacage-Based Host–Guest Complexation for Photodynamic Therapy

Programmed cyclodextrin-based core–shell nanoparticles for cooperative TGF-β blockade to reverse immunosuppression post photodynamic therapy

Photocontrollable release and enhancement of photodynamic therapy based on host–guest supramolecular amphiphiles

Novel dual-mode antitumor chlorin-based derivatives as potent photosensitizers and histone deacetylase inhibitors for photodynamic therapy and chemotherapy

Amphiphilic porphyrin-based supramolecular self-assembly for photochemotherapy: From molecular design to application

Redox-responsive supramolecular amphiphiles constructed via host-guest interactions for photodynamic therapy

A Dual‐Functional Photosensitizer for Ultraefficient Photodynamic Therapy and Synchronous Anticancer Efficacy Monitoring

Macrocyclic Versus Acyclic Preorganization in Organoplatinum(ii)-Based Host‒guest Complexes